DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q3 2022

SEC EDGAR SourceSEC Filings

Top Holdings343 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3.5M$236.6M3.6%$54.00+21.75%
15 qtrssince 2019-Q1
Decreased
0

XENON PHARMACEUTICALS INC

4.5M$162.6M2.5%$25.93+38.41%
11 qtrssince 2020-Q1
Increased
53

CAMECO CORP

5.2M$137.4M2.1%$23.30+14.53%
5 qtrssince 2021-Q3
Increased
54

CRINETICS PHARMACEUTICALS IN

5.6M$110.6M1.7%$20.84-7.37%
10 qtrssince 2020-Q2
Increased
49

CALIX INC

1.7M$104M1.6%$46.85+28.15%
9 qtrssince 2020-Q3
Increased
76

WILLSCOT HOLDINGS CORP

2.5M$100.3M1.5%$35.31+11.53%
5 qtrssince 2021-Q3
Decreased
0
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

4.2M$88.9M1.3%$14.14+44.73%
15 qtrssince 2019-Q1
Increased
51

Xometry, Inc. Class A

1.5M$87.9M1.3%$47.50+20.46%
4 qtrssince 2021-Q4
Increased
76

CHART INDS INC

429,144$79.1M1.2%$136.44+34.37%
12 qtrssince 2019-Q4
Increased
51

KINSALE CAP GROUP INC

306,997$78.4M1.2%$229.89+11.99%
4 qtrssince 2021-Q4
Decreased
0

CYTOKINETICS INC

1.6M$77.8M1.2%$12.27+298.84%
14 qtrssince 2019-Q2
Decreased
0

CELSIUS HOLDINGS INC

801,288$72.7M1.1%$13.82+119.15%
10 qtrssince 2020-Q2
Decreased
0

EPAM SYSTEMS INC

193,597$70.1M1.1%$341.71+5.98%
15 qtrssince 2019-Q1
Increased
75

LANTHEUS HOLDINGS INC

976,872$68.7M1.0%$58.19+18.59%
3 qtrssince 2022-Q1
Increased
52

Impinj, Inc.

846,433$67.7M1.0%$72.04+13.86%
7 qtrssince 2021-Q1
Increased
67

RELAY THERAPEUTICS INC

3M$66.4M1.0%$35.80-35.37%
9 qtrssince 2020-Q3
Decreased
0

PAYLOCITY HLDG CORP

274,661$66.4M1.0%$211.35+16.58%
3 qtrssince 2022-Q1
Increased
56
TCOMTCOM
ADR

TRIP.COM GROUP LTD-ADR

2.2M$60.7M0.9%$27.32-0.97%
2 qtrssince 2022-Q2
Increased
67

ATI INC

2.3M$60.3M0.9%$26.53+3.97%
3 qtrssince 2022-Q1
Decreased
0

MGP INGREDIENTS INC NEW

565,358$60M0.9%$86.57+16.70%
6 qtrssince 2021-Q2
Increased
42
$6.6B
AUM
343
Positions
Q3 2022
Filing
Rating · 2.0
Quarterly Portfolio Change
+11%Q2'21$7.5B+12%Q3'21$8.4B+16%Q4'21$9.8B-17%Q1'22$8.1B-24%Q2'22$6.2B+7%Q3'22$6.6B
Activity profile
$ moved · Q3'22
New22%Increased31%Decreased23%Exited24%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.7 years
<1Q11%1-4Q21%1-2Y24%2Y+43%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $6.6B across 343 positions as of Q3 2022. Top holdings: TSM (3.6%), XENE (2.5%), CCJ (2.1%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q3 2022 Summary

Active quarter - 82 new positions, 90 exits, 117 increased. Top move: CALX (INCREASED, conviction 76). Portfolio: $6.6B across 343 positions.

Top holdings by portfolio weight

Total AUM$7B
TSM3.58%
XENE2.46%
CCJ2.08%
CRNX1.67%
CALX1.57%
WSC1.52%
IBN1.35%
XMTR1.33%
GTLS1.20%
KNSL1.19%
Other1.18%

Portfolio allocation by GICS sector

Sectors11
Technology19.72%
Healthcare18.88%
Industrials14.02%
Unknown13.99%
Consumer Cyclical10.14%
Consumer Defensive6.93%
Financial Services5.87%
Energy5.25%
Basic Materials2.90%
Communication Services1.72%
Other0.56%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Technology, Healthcare, Industrials
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used